disseminated intravascular coagulation
Information
- Disease name
- disseminated intravascular coagulation
- Disease ID
- DOID:11247
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06373159 | Active, not recruiting | An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in Japan | April 10, 2024 | September 30, 2024 | |
| NCT00487656 | Completed | Phase 2 | Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation | July 2007 | August 2010 |
| NCT01704001 | Completed | Phase 4 | Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment | October 2012 | June 2014 |
| NCT04356144 | Completed | Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections | April 15, 2020 | February 1, 2021 | |
| NCT03714048 | Completed | Blood Management During ECMO for Cardiac Support | July 1, 2019 | April 15, 2023 | |
| NCT03716310 | Completed | Platelet Reactivity in Septic Shock | April 1, 2017 | August 30, 2018 | |
| NCT04356950 | Completed | Analysis of the Coagulopathy Developed by COVID-19 Infected Patients | April 28, 2020 | June 2, 2022 | |
| NCT04460664 | Completed | Coagulation Changes Associated With COVID-19 Infection | August 14, 2020 | January 26, 2022 | |
| NCT04547153 | Completed | Phase 2 | Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC | January 15, 2021 | March 22, 2024 |
| NCT04580563 | Completed | N/A | Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study | October 22, 2020 | January 3, 2023 |
| NCT04873349 | Completed | N/A | Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients | May 10, 2021 | August 1, 2022 |
| NCT06363149 | Recruiting | Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients | April 12, 2024 | September 2025 | |
| NCT02654561 | Recruiting | Phase 3 | Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation | April 12, 2018 | June 2025 |
| NCT05995093 | Recruiting | The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation | December 1, 2022 | June 30, 2024 | |
| NCT00506519 | Terminated | Phase 2 | Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis | July 2007 | March 2009 |
| NCT00299949 | Terminated | Thrombin Generation and Thromboelastography in Non-overt DIC | October 2006 | December 2008 | |
| NCT04107402 | Unknown status | N/A | PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock | March 15, 2019 | March 15, 2024 |
| NCT03577015 | Unknown status | International Prospective Registry of Disseminated Intravascular Coagulation | November 1, 2017 | June 1, 2021 | |
| NCT04363840 | Withdrawn | Phase 2 | The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations | May 2020 | December 2020 |
- Disase is a (Disease Ontology)
- DOID:2452
- Cross Reference ID (Disease Ontology)
- ICD10CM:D65
- Cross Reference ID (Disease Ontology)
- ICD9CM:286.6
- Cross Reference ID (Disease Ontology)
- MESH:D004211
- Cross Reference ID (Disease Ontology)
- NCI:C2992
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:67406007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0012739
- Exact Synonym (Disease Ontology)
- Defibrination syndrome
- Exact Synonym (Disease Ontology)
- DIC
- Exact Synonym (Disease Ontology)
- Diffuse or disseminated intravascular coagulation
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0005521
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004211